Additionally, in an immunocompetent model of obesity-associated breast cancer, perhexiline treatment led to significant tumour inhibition that corresponded with infiltration of interferon-gamma and granzyme b producing CD8+ T cells [86]. The gene discussed is CD8A; the disease is obesity due to melanocortin 4 receptor deficiency.